Heparin-bonded central venous catheters do not reduce thrombosis in infants with congenital heart disease: A blinded randomized, controlled trial

Pediatrics

Volumn 123, Issue 3, 2009, Pages

  Anton, Natalie ^a   Cox, Peter N ^b   Massicotte, M Patricia ^a   Chait, Peter ^b   Yasui, Yutaka ^c   Dinyari, P Maria ^a   Marzinotto, Velma ^b   Mitchell, Lesley G ^a,c  

^a STOLLERY CHILDREN S HOSPITAL   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Catheters; Pediatrics; Prevention; Thrombosis

Indexed keywords

HEPARIN; BIOMATERIAL;

ARTICLE; CENTRAL VENOUS CATHETER; CHILD CARE; CLINICAL TRIAL; CONGENITAL HEART DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ECHOGRAPHY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; THROMBOSIS; TREATMENT OUTCOME; BLOOD; CENTRAL VENOUS CATHETERIZATION; CONGENITAL HEART MALFORMATION; CROSS-SECTIONAL STUDY; DOUBLE BLIND PROCEDURE; INFANT; INSTRUMENTATION; NEWBORN;

CATHETERIZATION, CENTRAL VENOUS; COATED MATERIALS, BIOCOMPATIBLE; CROSS-SECTIONAL STUDIES; DOUBLE-BLIND METHOD; FEMALE; HEART DEFECTS, CONGENITAL; HEPARIN; HUMANS; INFANT; INFANT, NEWBORN; MALE; THROMBOSIS; ULTRASONOGRAPHY;

EID: 63149156321     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-1508     Document Type: Article

References (14)

1. Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood. 1994;83(5):1251-1257
2. Talbott GA, Winters WD, Bratton SL, O'Rourke PP. A prospective study of femoral catheter-related thrombosis in children. Arch Pediatr Adolesc Med. 1995;149(3):288-291
3. Chaukiyal P, Nautiyal A, Radhakrishnan S, Singh S, Navaneethan SD. Thromboprophylaxis in cancer patients with central venous catheters: a systematic review and meta-analysis. Thromb Haemost. 2008;99(1):38-43
4. Ruud E, Holmstrom H, De Lange C, Hogstad EM, Wesenberg F. Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies: a randomized, controlled study. Acta Paediatr. 2006;95(9):1053-1059
5. Laster JL, Nichols WK, Silver D. Thrombocytopenia associated with heparin-coated catheters in patients with heparin-associated antiplatelet antibodies. Arch Intern Med. 1989;149(10):2285-2287
6. Krafte-Jacobs B, Sivit CJ, Mejia R, Pollack MM. Catheter-related thrombosis in critically ill children: comparison of catheters with and without heparin bonding. J Pediatr. 1995;126(1):50-54
7. Pierce CM, Wade A, Mok Q. Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children. Intensive Care Med. 2000;26(7):967-972
8. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized, controlled trials. Chest. 1998;113(1):165-171
9. Hingorani A, Ascher E, Lorenson E, et al. Upper extremity deep venous thrombosis and its impact on morbidity and mortality rates in a hospital-based population. J Vasc Surg. 1997;26(5):853-860
10. Marie I, Levesque H, Cailleux N, et al. Deep venous thrombosis of the upper limbs: apropos of 49 cases [in French]. Rev Med Interne. 1998;19(6):399-408
11. Massicotte MP, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr. 1998;133(6):770-776
12. Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res. 2000;47(6):763-766
13. Kuhle S, Spavor M, Massicotte P, et al. Prevalence of post-thrombotic syndrome following asymptomatic thrombosis in survivors of acute lymphoblastic leukemia. J Thromb Haemost. 2008;6(4):589-594
14. Mitchell LG, Andrew M, Hanna K, et al. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids With Acute Lymphoblastic Leukemia Treated With Asparaginase (PARKAA) Study. Cancer. 2003;97(2):508-516